1-7 of 7
Anas Younes
Close
Sort by
Journal Articles

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma

Clinical Trials & Observations
Anas Younes, John M. Burke, Bruce D. Cheson, Catherine S. Diefenbach, Silvia Ferrari, Uwe H. Hahn, Eliza A. Hawkes, Cyrus Khan, Izidore S. Lossos, Gerardo Musuraca, Monica Tani, Umberto Vitolo, Sam Yuen, Aparna Raval, Mahesh Shivhare, Tina G. Nielsen, Gila Sellam, Jeff P. Sharman
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1488–1495.
https://doi.org/10.1182/bloodadvances.2022008344
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma

Anas Younes, John M. Burke, Catherine Diefenbach, Silvia Ferrari, Cyrus Khan, Jeff P. Sharman, Monica Tani, Chaitra Ujjani, Umberto Vitolo, Sam Yuen, Aparna Raval, Mahesh Shivhare, Tina G. Nielsen, Gila Sellam, Michael Gilbertson
Journal: Blood Advances
Blood Adv (2022) 6 (20): 5659–5667.
https://doi.org/10.1182/bloodadvances.2021006131
Published: 2022
Includes: Supplemental data
Journal Articles

A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma

Clinical Trials & Observations
David Qualls, Hiu Ying Lam, Karissa Whiting, Anita Kumar, Matthew Matasar, Colette Owens, Chelsea Nichols, James A Espeleta, Annie Qiu, Sarima Subzwari, Erin Biggar, Venkatraman Seshan, Gilles Salles, Anas Younes, Connie Batlevi
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5262–5266.
https://doi.org/10.1182/bloodadvances.2021006555
Published: 2022
Includes: Supplemental data
Journal Articles

Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue

Clinical Trials & Observations
Erel Joffe, Yan Leyfman, Esther Drill, Sridevi Rajeeve, Andrew D. Zelenetz, M. Lia Palomba, Craig H. Moskowitz, Carol Portlock, Ariela Noy, Steven M. Horwitz, John F. Gerecitano, Alison Moskowitz, Paul Hamlin, Matthew J. Matasar, Anita Kumar, Connie L. Batlevi, Anas Younes, David J. Straus
Journal: Blood Advances
Blood Adv (2021) 5 (2): 345–351.
https://doi.org/10.1182/bloodadvances.2020003213
Published: 2021
Journal Articles

Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies

Clinical Trials & Observations
David Sermer, Connie Batlevi, M. Lia Palomba, Gunjan Shah, Richard J. Lin, Miguel-Angel Perales, Michael Scordo, Parastoo Dahi, Martina Pennisi, Aishat Afuye, Mari Lynne Silverberg, Caleb Ho, Jessica Flynn, Sean Devlin, Philip Caron, Audrey Hamilton, Paul Hamlin, Steven Horwitz, Erel Joffe, Anita Kumar, Matthew Matasar, Ariela Noy, Colette Owens, Alison Moskowitz, David Straus, Gottfried von Keudell, Ildefonso Rodriguez-Rivera, Lorenzo Falchi, Andrew Zelenetz, Joachim Yahalom, Anas Younes, Craig Sauter
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4669–4678.
https://doi.org/10.1182/bloodadvances.2020002118
Published: 2020
Includes: Supplemental data
Journal Articles

Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
David Sermer, Sabela Bobillo, Ahmet Dogan, Yanming Zhang, Venkatraman Seshan, Jessica A. Lavery, Connie Batlevi, Philip Caron, Audrey Hamilton, Paul Hamlin, Steven Horwitz, Erel Joffe, Anita Kumar, Matthew Matasar, Ariela Noy, Colette Owens, Alison Moskowitz, M. Lia Palomba, David Straus, Gottfried von Keudell, Ildefonso Rodriguez-Rivera, Lorenzo Falchi, Andrew Zelenetz, Joachim Yahalom, Anas Younes
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3382–3390.
https://doi.org/10.1182/bloodadvances.2020001551
Published: 2020
Includes: Supplemental data
Journal Articles

Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma

Clinical Trials & Observations
Anita Kumar, Santosha Vardhana, Alison J. Moskowitz, Pierluigi Porcu, Ahmet Dogan, Jason A. Dubovsky, Matthew J. Matasar, Zhigang Zhang, Anas Younes, Steven M. Horwitz
Journal: Blood Advances
Blood Adv (2018) 2 (8): 871–876.
https://doi.org/10.1182/bloodadvances.2017011916
Published: 2018
Includes: Supplemental data